This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2013 by Jean Grem, MD, University of Nebraska
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Adherex Technologies, Inc.
Information provided by (Responsible Party):
Jean Grem, MD, University of Nebraska
ClinicalTrials.gov Identifier:
NCT01825603
First received: March 27, 2013
Last updated: May 7, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)